Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis.
Novembre E, Galli E, Landi F, Caffarelli C, Pifferi M, De Marco E, Burastero SE, Calori G, Benetti L, Bonazza P, Puccinelli P, Parmiani S, Bernardini R, Vierucci A.
Novembre E, et al. Among authors: burastero se.
J Allergy Clin Immunol. 2004 Oct;114(4):851-7. doi: 10.1016/j.jaci.2004.07.012.
J Allergy Clin Immunol. 2004.
PMID: 15480326
Clinical Trial.